At Onyx Newsroom, we are committed to delivering journalism that is accurate, independent, and trusted. As a leading voice in biotechnology, pharmaceuticals, and global business, our readers rely on us for reporting that is both authoritative and uncompromising in its standards.

Accuracy lies at the heart of our work. Every story is rigorously checked against primary sources: from regulatory filings and clinical trial data to peer-reviewed studies and financial disclosures. We aim to provide clarity in complex fields, distinguishing fact from analysis, and ensuring our readers can rely on our coverage to inform decisions.

Our independence is non-negotiable. Editorial decisions are made without influence from advertisers, sponsors, or corporate interests. Any sponsored content is clearly labeled, and advertising never dictates what we cover.

We also believe in accountability and transparency. Mistakes are corrected promptly and openly, and readers are encouraged to raise concerns directly with our editors. Concerns or corrections can be sent to Dr. Adil Ali, Editor-in-Chief, at adil@onyxnewsroom.com. We treat sensitive issues with professionalism, respect, and dignity.

Onyx Newsroom reflects the diversity of the industries we cover. We are committed to amplifying a broad range of voices across geographies, disciplines, and perspectives.

Above all, we exist to serve our readers with journalism that is clear, fair, and principled.

Advertising Enquiries

For advertising and partnership opportunities, please contact Lewis Hart, Managing Director: lewis@onyxnewsroom.com.